Improved adjuvant therapy of g250-expressing tumors

Details Improved adjuvant therapy of g250-expressing tumors Improved adjuvant therapy of g250-expressing tumors

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2566950

The invention relates to a method for the treatment of G250-antigen-expressing tumors, in particular renal clear cell carcinoma comprising the administration of G250-antigen-specific antibodies to high-risk patients diagnosed with non- metastasising disease.

L'invention porte sur un procédé de traitement des tumeurs exprimant l'antigène G250, en particulier le carcinome à cellules claires rénales, qui consiste à administrer des anticorps spécifiques de l'antigène G250 à des patients à haut risque chez lesquels on a diagnostiqué une maladie non métastasante.

Affiliated with

Also associated with

Rating

Improved adjuvant therapy of g250-expressing tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved adjuvant therapy of g250-expressing tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved adjuvant therapy of g250-expressing tumors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1671745